Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Recombinant fragment corresponding to a region within amino acids 252 and 487 of Human DOC1|
|Purification||Antigen affinity chromatography|
|Storage buffer||PBS, pH 7, with 1% BSA, 20% glycerol|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA5-32021 targets DOC1 in WB applications and shows reactivity with Human samples.
The PA5-32021 immunogen is recombinant fragment corresponding to a region within amino acids 252 and 487 of Human DOC1.
Acts as a regulator of the antiangiogenic activity on endothelial cells. When overexpressed in endothelial cells, leads to inhibition of cell proliferation and migration and an increase in apoptosis. Inhibits melanoma growth When expressed in tumor-associated vasculature.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
130 kDa GPBP-interacting protein; 90 kDa GPBP-interacting protein; DOC-1; DOC1; downregulated in ovarian cancer 1 81 kDa isoform; filamin A interacting protein 1-like; Filamin A-interacting protein 1-like; GIP130; GIP130a; GIP130b; GIP130c; GIP90; GPBP-interacting protein 90; GPBP-interacting protein of 130 kDa; protein down-regulated in ovarian cancer; Protein down-regulated in ovarian cancer 1
COL4A3BPIP; DOC-1; DOC1; FILIP1L; GIP130; GIP90